Progetti FP7 coordinati da "Hospices cantonaux chuv"
| # | ||||
|---|---|---|---|---|
| 1 | LASSA VIRUS RECEPTOR The interaction of Lassa virus with its cellular receptor alpha-dystroglycan | 2008 | 100˙000.00 | 100˙000.00 |
| 2 | IDEA Dissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections: An African-European Research Initiative | 2010 | 13˙728˙795.00 | 10˙300˙000.00 |
| 3 | LCMVACC Prophylactic and therapeutic use of recombinant lymphocytic choriomeningitis virus against melanoma | 2012 | 192˙622.00 | 192˙622.00 |
| 4 | BRAINVECTORS "From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV" | 2012 | 1˙597˙783.00 | 1˙597˙783.00 |
| 5 | SYSCLAD Systems prediction of Chronic Lung Allograft Dysfunction | 2012 | 3˙932˙547.00 | 2˙999˙152.00 |
| 6 | ANTIVESSEL-T-CELLS Development of Vascular-Disrupting Lymphocyte Therapy for Tumours | 2013 | 2˙500˙000.00 | 2˙500˙000.00 |
| 7 | PROTECTC Identify novel pathways to enhance the induction of protective CD8+ T cell responses | 2013 | 1˙499˙850.00 | 1˙499˙850.00 |
Altri progetti
L'Ente hospices cantonaux chuv partecipato anche in questi progetti.
- KIEKIDS (2011, participant)
- Commodity12 (2011, participant)
- Linked2Safety (2011, participant)
- ADHOPHTA (2012, participant)
- HIT HIDDEN HIV (2012, participant)
- PHAGOBURN (2013, participant)
- EPIONE (2013, participant)
- EUTEMPE-RX (2013, participant)
- ANTIVESSEL-T-CELLS (2013, hostInstitution)
- ANTIVESSEL-T-CELLS (2013, hostInstitution)
- HBP (2013, participant)
- PROTECTC (2013, hostInstitution)
- PROTECTC (2013, hostInstitution)
- ORAMED (2008, participant)
- NANOIMPACTNET (2008, participant)
- NANOTEST (2008, participant)
- OPTISTEM (2009, participant)
- ALLFUN (2010, participant)
- HEPACUTE (2010, participant)
- ENDOTOFPET-US (2011, participant)
- PANACREAS (2011, participant)
- HBP (2011, participant)